Skip to main content

COVID 19 Updates from RheumNow

A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Ready for Telemedicine/Telerheumatology?

Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction.  If you have the ability and the capacity, record the visit. 

The COVID-19 Global Rheumatology Registry

As the highly virulent SARS-CoV-2 spreads over the world, uncertainty and fear for our patients with rheumatic diseases mount.  

Rheumatic Disease Drugs and COVID-19

We are in the early stages of trying to limit the morbid and mortal consequences of the corona virus pandemic of 2020.  Not surprisingly, the recommendations designed to limit exposure and damage continually highlight the fact that the elderly and immunosuppressed may be amongst the most sev

RheumNow Podcast- Corona Increases RA Risk (3.13.20)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Social

COVID-19 has been tough on everyone, but especially tough on our patients in rheumatology. We need to think about the long-term impacts, but also about how we can do it better next time. @HSpecialSurgery #ACR21 ABST0266 @RheumNow https://t.co/JdOqZ8Svin https://t.co/c0rlY9PfDv
David Liew @drdavidliew ( View Tweet )
2 years 5 months ago
“It all begins with empathy!” Dr. Karp regarding difficult unknown/long haul COVID19 symptoms in our patients. #ACR21 @RheumNow

Dr. Rachel Tate @uptoTate ( View Tweet )

2 years 5 months ago
Michael Brenner, Basic Science Year in review: Auto-antibodies against interferon, present prior to COVID-19, mostly in men and increases with age: increases risk to #COVID19 mortality #ACR21 @RheumNow https://t.co/5sFqcBtStD
2 years 5 months ago
OK this one is cool. RNA technology used as pro inflammatory in #COVID #vaccinations but paper of RNA vector giving immunetolerance in mouse model of encephalitis. #ACRBest Yr in Review by M Brenner discussion of paper. Double edged sword ⚔️ @RheumNow #ACR21 https://t.co/8sRl351D27
2 years 5 months ago
Join us tomorrow at #ACR21 in the #COVID19 hub at 12p EST where I’ll be discussing outpatient management of high risk covid patients with @LCalabreseDO #mAbs @philipcrobinson @ACRheum https://t.co/LkSw48cnWw
Cassandra Calabrese @CCalabreseDO ( View Tweet )
2 years 5 months ago
#ACR21 Anti-IFN autoantibodies predisposing patients to severe COVID ...🤔 And can be done with quantiferon test! https://t.co/n3h4vpQGdR
LiSa ◡̈︎ @rheumarhyme ( View Tweet )
2 years 5 months ago
MMWR reports those who have recv COVID-19 vaccine have lower risk non–COVID-19 mortality (vs unvaccinated). Adjusted rel risk of non–COVID-19 death for Pfizer-vaccine (2 doses RR 0.34), Moderna (0.31), Janssen (0.54). NO INCR MORTAL RISK IN VACCINATED https://t.co/X6X1w1aYoU

Dr. John Cush @RheumNow ( View Tweet )

2 years 5 months ago
New Download Available! FDA EUA for Baricitinib in COVID https://t.co/yTQLb7DDvR https://t.co/n9Npg0Pq5q
Dr. John Cush @RheumNow ( View Tweet )
2 years 5 months ago
From March to Dec 2020, study of 116K COVID pts saw monthly rates of hospitalization (105/100K), ICU admits (20/100K), & death (12/100K) -peaked 12/20. Highest w/ age >65yrs, hispanics, blacks. Remdesivir incr 1.7% to 54%; Steroids 19% to 74.2% https://t.co/5pzu74YIz6

Dr. John Cush @RheumNow ( View Tweet )

2 years 5 months ago
Israeli study of 1497 fully vaccinated health care workers finds 39 (2.4% Breakthrough COVID infections (Jan-May 2021), most cases were mild or asymptomatic, 19% w/ persistent Sxs (>6 ws); infected had lower neutralizing Abs. https://t.co/deYTVLRQCU

Dr. John Cush @RheumNow ( View Tweet )

2 years 5 months ago